Today: 16 May 2026
S&P 500 Breaks 200-Day Moving Average as Iran Oil Shock Splits Wall Street on What Comes Next
23 March 2026
2 mins read

S&P 500 Breaks 200-Day Moving Average as Iran Oil Shock Splits Wall Street on What Comes Next

NEW YORK, March 23, 2026, 10:13 EDT

Last week’s slip under the S&P 500’s 200-day moving average has market analysts at odds—some see the start of a bigger correction, others are eyeing a possible bounce. On Monday, that split got starker. Stocks rebounded, oil dropped, and President Donald Trump announced a delay to planned strikes on Iranian power plants and energy facilities.

The 200-day moving average—basically the mean close across the prior 200 sessions—just snapped. Funds and risk managers lean on this marker for a read on the long-term trend. This time, though, the break follows four straight down weeks, spiking oil, and a hawkish shift from central banks, which amps up the significance well beyond a typical chart blip.

Shooting higher by 9:40 a.m. ET Monday, the S&P 500 climbed 1.52% to 6,605.26; the Dow Jones Industrial Average picked up 1.66%. The Nasdaq Composite jumped 1.77%, with the CBOE Volatility Index retreating from its recent two-week peak. Brent crude tumbled as much as 15%, trading at $96 a barrel, and U.S. crude slid 13.5% to $85.28, coming after Trump’s five-day reprieve.

Lance Roberts, chief investment strategist at Real Investment Advice, flagged the real question: “what kind of break is this?” In his analysis of a dozen instances since 2000, he counted seven persistent breaks that led to an average one-month loss of 5.3% and a 12-month average drop of 4.0%. The five other, more fleeting breaks? Those saw the market rally, with an average 12-month gain of 19.8%. RIA

Phil Rosen at Inc. struck a more optimistic note, pointing out that the S&P 500 slipped under its 200-day moving average for the first time in 214 trading sessions. He referenced TradingView numbers—16 such drops in the last ten years, many of which were followed by rebounds instead of extended declines. Rosen also flagged that both the Dow and Nasdaq wrapped up last week under their 200-DMA too.

Andrew McElroy, Matrixtrade’s chief analyst, took a tighter view in his Seeking Alpha note. He flagged a possible rebound around 6,500, but called resistance up at 6,764 to 6,775—pointing to persistent inflation and waning Fed cut bets as the roadblocks for further gains. For a bigger-picture entry, he’s eyeing 6,147.

Other analysts echoed the unease on Monday. Chris Larkin, managing director of trading and investing at E*TRADE from Morgan Stanley, described markets as “headline-driven.” Aaron Costello, who leads Asia at Cambridge Associates, cautioned that investors have begun factoring in the risk that stockpiles “will eventually be depleted” should the conflict persist. Reuters

This wasn’t a one-off. Inc. noted both the Nasdaq and Dow dipped under their 200-day averages, and that Monday’s bounce only lifted a handful of names: American Airlines and United Airlines both surged over 4.5%. Cruise stocks leapt more than 5.5%. On the other side, oil names like Exxon Mobil, Chevron, and Occidental Petroleum slipped as crude prices pulled back.

The bigger worry here: the rebound could quickly unravel. Iran’s Fars News Agency pushed back on Trump’s claims about backchannel talks with Washington. Over at Goldman Sachs, analysts warned that if the Strait of Hormuz stays choked off, Brent might stick close to $110 through March and April. In a worst-case outcome, prices could spike to $135—a move that would likely hit stocks again and push expectations for rate cuts even further out.

Right now, there’s a technical break, a spark from geopolitics, and still no clear resolution. Roberts called the 200-DMA “not a verdict” but more of an open question; Monday’s bounce only addressed a piece of that puzzle. RIA

Stock Market Today

  • Artemis Medicare Services' Earnings Boosted by Share Dilution, Raises Caution for Investors
    May 16, 2026, 1:08 AM EDT. Artemis Medicare Services (NSE:ARTEMISMED) reported strong earnings with a 25% profit increase in the last year, but share dilution raised the number of shares by 14%, softening earnings per share (EPS) growth to 22%. Over three years, profit rose 168%, while EPS grew 127%, highlighting dilution's impact. Dilution means each shareholder's piece of profit shrinks despite overall profit growth. Persistent EPS growth is crucial for true shareholder value and share price increase. Investors should examine additional factors such as margins, forecast growth, and return on investment to fully assess Artemis Medicare's earnings quality and future performance.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Nvidia Stock Price Rebounds as Oil Slides, but Questions Over AI Returns Linger
Previous Story

Nvidia Stock Price Rebounds as Oil Slides, but Questions Over AI Returns Linger

Microsoft Stock Selloff Sparks Fresh Buy Calls, but AI Spending Risks Linger
Next Story

Microsoft Stock Selloff Sparks Fresh Buy Calls, but AI Spending Risks Linger

Go toTop